| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00281-008-0110-Y |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s00281-008-0110-y |
| P932 | PMC publication ID | 2315691 |
| P698 | PubMed publication ID | 18299835 |
| P5875 | ResearchGate publication ID | 5552185 |
| P2093 | author name string | Nalini S Bora | |
| Puran S Bora | |||
| Purushottam Jha | |||
| P2860 | cites work | Complement factor H: spatial and temporal expression and localization in the eye | Q80175120 |
| Drusen complement components C3a and C5a promote choroidal neovascularization | Q24303123 | ||
| A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration | Q24523983 | ||
| Isolation and characterization of a membrane-attack-complex-inhibiting protein present in human serum and other biological fluids | Q24528248 | ||
| Complement factor H polymorphism in age-related macular degeneration | Q24553334 | ||
| Structural basis for complement factor H linked age-related macular degeneration | Q24676448 | ||
| Differential gene expression in anatomical compartments of the human eye. | Q24814005 | ||
| Complement factor H variant increases the risk of age-related macular degeneration | Q28239239 | ||
| Differential expression of the complement regulatory proteins in the human eye | Q28285403 | ||
| Molecular organization and function of the complement system | Q28289114 | ||
| Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster | Q28304963 | ||
| CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration | Q28512384 | ||
| Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization | Q28513118 | ||
| Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells | Q28565650 | ||
| Alcohol linked to enhanced angiogenesis in rat model of choroidal neovascularization | Q28567980 | ||
| Identification and functional characterization of a new gene encoding the mouse terminal complement inhibitor CD59 | Q28589130 | ||
| Complement factor H polymorphism and age-related macular degeneration | Q29614931 | ||
| Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation | Q30817180 | ||
| Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H. | Q30819789 | ||
| Comparison of the N-linked glycans from soluble and GPI-anchored CD59 expressed in CHO cells | Q31065746 | ||
| Molecular cloning of rat and mouse membrane cofactor protein (MCP, CD46): preferential expression in testis and close linkage between the mouse Mcp and Cr2 genes on distal chromosome 1. | Q31983999 | ||
| T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. | Q32068656 | ||
| Age-related macular degeneration (AMD): pathogenesis and therapy | Q33250352 | ||
| Pathogenesis of laser-induced choroidal subretinal neovascularization | Q33254687 | ||
| Estimation of systemic complement C3 activity in age-related macular degeneration | Q33281594 | ||
| Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin | Q33283093 | ||
| Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction | Q33301870 | ||
| The simple design of complement factor H: Looks can be deceiving | Q33372312 | ||
| Genetic susceptibility to age related macular degeneration | Q33831396 | ||
| Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease | Q33899675 | ||
| Structure-function relationships of complement receptor type 1. | Q33952060 | ||
| Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration | Q34066021 | ||
| Biological effects of C1 inhibitor | Q34363269 | ||
| Control of the complement system. | Q34400002 | ||
| Complement activation and inflammatory processes in Drusen formation and age related macular degeneration | Q34521109 | ||
| Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement | Q34537546 | ||
| Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration | Q34561066 | ||
| Complement C3 variant and the risk of age-related macular degeneration | Q34651682 | ||
| Mechanisms of age-related macular degeneration. | Q34684544 | ||
| Immune privilege in the anterior chamber of the eye. | Q34788773 | ||
| Membrane inhibitor of reactive lysis | Q35344434 | ||
| Decay accelerating factor (CD55). | Q35344453 | ||
| Membrane cofactor protein | Q35483434 | ||
| Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59. | Q35677703 | ||
| Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. | Q35750345 | ||
| A review of treatments for macular degeneration: a synopsis of currently approved treatments and ongoing clinical trials | Q35760590 | ||
| Functions of human complement inhibitor C4b-binding protein in relation to its structure | Q35793072 | ||
| The complement system plays a critical role in the development of experimental autoimmune anterior uveitis | Q35989062 | ||
| Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein | Q36364346 | ||
| Decay-Accelerating Factor and Membrane Cofactor Protein | Q36556201 | ||
| Subretinal neovascularization. Natural history of an experimental model | Q36590902 | ||
| Age-Related Macular Degeneration and Blindness due to Neovascular Maculopathy | Q36592901 | ||
| Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing | Q36679434 | ||
| Intraocular diseases - anterior uveitis | Q36722849 | ||
| Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications | Q36814119 | ||
| The role of complement in inflammation and phagocytosis | Q36845189 | ||
| Molecular cloning, chromosomal localization, expression, and functional characterization of the mouse analogue of human CD59. | Q36846093 | ||
| Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein | Q36860930 | ||
| The role of complement system in ocular diseases including uveitis and macular degeneration | Q36927874 | ||
| Effect of C3 depletion on experimental Pseudomonas aeruginosa ocular infection: histopathological analysis | Q37096638 | ||
| Activation and control of the complement system | Q39761363 | ||
| Alternate Pathway Activation of Complement in a Proteus mirabilis Ulceration of the Cornea | Q40930848 | ||
| Extrahepatic complement biosynthesis: where, when and why? | Q41331539 | ||
| Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1. | Q41494520 | ||
| Identification of a potent new pathogenic site in human retinal S-antigen which induces experimental autoimmune uveoretinitis in LEW rats | Q41731846 | ||
| A potential role for immune complex pathogenesis in drusen formation | Q41743141 | ||
| Generation of complement-derived anaphylatoxins in normal human donor corneas. | Q43621679 | ||
| The effect of systemic decomplementation with cobra venom factor on corneal complement levels in guinea pigs | Q44015454 | ||
| Role of complement in murine corneal infection caused by Pseudomonas aeruginosa. | Q44442651 | ||
| Generation of complement membrane attack complex in normal human corneas. | Q45969274 | ||
| Genetic deficiency of C3 as well as CNS-targeted expression of the complement inhibitor sCrry ameliorates experimental autoimmune uveoretinitis | Q46688037 | ||
| Complement deposits on ocular tissues adjacent to sites of inflammation | Q46890475 | ||
| Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU). | Q47298991 | ||
| Type I collagen is the autoantigen in experimental autoimmune anterior uveitis | Q47578616 | ||
| Separation of self from non-self in the complement system | Q47688509 | ||
| Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes. Duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms. | Q48070636 | ||
| Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor. | Q50207373 | ||
| Effect of chronic ethanol consumption on the expression of complement components and acute-phase proteins in liver. | Q51902264 | ||
| Complement and complement regulatory proteins in human tears. | Q53977565 | ||
| Hemolytic complement activity in normal human donor corneas | Q67241367 | ||
| Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland | Q67661602 | ||
| Anaphylatoxin levels in human aqueous humor | Q68802064 | ||
| [The dynamics of leucocytes and complements in endotoxin induced uveitis] | Q69743891 | ||
| Distribution of hemolytic complement in the normal cornea | Q70165529 | ||
| Activated complement in inflamed aqueous humor | Q71010555 | ||
| Alternate and classical pathway components of complement in the normal cornea | Q71493079 | ||
| Tissue distribution of complement regulatory membrane proteins in rats | Q71626863 | ||
| Hemolytic complement activity in aqueous humor | Q71678376 | ||
| Localization of the complement membrane attack complex inhibitor (CD59) in human conjunctiva and lacrimal gland | Q71688788 | ||
| A new model of subretinal neovascularization in the rabbit | Q72016863 | ||
| Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF | Q72098270 | ||
| Complement inhibitor of rat cell membrane resembling mouse Crry/p65 | Q72332712 | ||
| Human corneal extract enhances serum complement activity | Q72754900 | ||
| Release of complement regulatory proteins from ocular surface cells in infections | Q73657409 | ||
| Cell surface regulators of complement, 5I2 antigen, and CD59, in the rat eye and adnexal tissues | Q78019721 | ||
| P433 | issue | 2 | |
| P921 | main subject | pathology | Q7208 |
| blood proteins | Q425056 | ||
| eye disease | Q3041498 | ||
| complement system proteins | Q67999591 | ||
| P304 | page(s) | 85-95 | |
| P577 | publication date | 2008-02-26 | |
| 2008-04-01 | |||
| P1433 | published in | Seminars in Immunopathology | Q15724576 |
| P1476 | title | The role of complement in ocular pathology | |
| P478 | volume | 30 |
| Q58493539 | Acanthamoeba |
| Q35075338 | Activated complement classical pathway in a murine model of oxygen-induced retinopathy |
| Q59055823 | Age-Related Macular Degeneration: Pathogenesis, Genetic Background, and the Role of Nutritional Supplements |
| Q36064197 | Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts |
| Q37714090 | Clusterin and complement activation in exfoliation glaucoma |
| Q35209209 | Comparison of genome-wide gene expression in suture- and alkali burn-induced murine corneal neovascularization. |
| Q35915651 | Complement System in the Pathogenesis of Benign Lymphoepithelial Lesions of the Lacrimal Gland |
| Q83228071 | Complement and CD4 T cells drive context-specific corneal sensory neuropathy |
| Q37553920 | Complement expression in the retina is not influenced by short-term pressure elevation |
| Q33984464 | Complement mediated apoptosis leads to the loss of retinal ganglion cells in animal model of glaucoma |
| Q34299745 | Complement regulatory protein CD46 protects against choroidal neovascularization in mice |
| Q35947745 | Copy number variations and gene polymorphisms of complement components in ocular Behcet's disease and Vogt-Koyanagi-Harada syndrome |
| Q45249469 | Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis |
| Q34624453 | Inhibition of complement alternative pathway suppresses experimental autoimmune anterior uveitis by modulating T cell responses |
| Q37678807 | Mediators of ocular angiogenesis |
| Q33683165 | Modified C-Reactive Protein Might be a Target Autoantigen of TINU Syndrome |
| Q37273740 | Molecular pathology of age-related macular degeneration |
| Q59137366 | New insight into the role of the complement in the most common types of retinopathy-current literature review |
| Q38038206 | Ocular actions of platelet-activating factor: clinical implications |
| Q88984389 | Plasma Exosomes Contribute to Microvascular Damage in Diabetic Retinopathy by Activating the Classical Complement Pathway |
| Q33880596 | Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization |
| Q34126362 | Resolution, the grail for healthy ocular inflammation |
| Q37116913 | Risk factors of uveitis in ankylosing spondylitis: An observational study |
| Q33683222 | Role of Ocular Complement Factor H in a Murine Model of Choroidal Neovascularization |
| Q41436924 | Suppression of complement activation by recombinant Crry inhibits experimental autoimmune anterior uveitis (EAAU). |
| Q42044277 | The Complement Regulatory Protein CD46 Deficient Mouse Spontaneously Develops Dry-Type Age-Related Macular Degeneration-Like Phenotype |
Search more.